U.S. Markets close in 4 hrs 9 mins

STADA Arzneimittel Aktiengesellschaft (SAZ.DE)

XETRA - XETRA Delayed Price. Currency in EUR
Add to watchlist
81.26+1.10 (+1.37%)
At close: 5:29PM CEST
Full screen
Previous Close80.16
Bid0.00 x 5000
Ask0.00 x 28500
Day's Range79.94 - 81.50
52 Week Range41.41 - 83.65
Avg. Volume428,827
Market Cap5.06B
PE Ratio (TTM)53.71
Earnings DateN/A
Dividend & YieldN/A (N/A)
Ex-Dividend DateN/A
1y Target EstN/A
  • Moody's12 days ago

    Nidda Healthcare Holding AG -- Moody's assigns (P)B2 CFR to Nidda BondCo GmbH, outlook stable

    Rating Action: Moody's assigns B2 CFR to Nidda BondCo GmbH, outlook stable. Global Credit Research- 07 Sep 2017. Frankfurt am Main, September 07, 2017-- Moody's Investors Service, has today assigned a ...

  • The Wall Street Journal14 days ago

    [$$] Bain, Cinven​Accept Elliott's Demand for a Higher Stada Price

    Elliott Management Corp., an activist hedge fund, wants at least a 12% premium to the takeover price.

  • Reuters15 days ago

    Bain, Cinven give in to Elliott's demand for higher Stada buyout

    Buyout groups Bain Capital and Cinven said they would propose to Stada's management to offer minority shareholders cash compensation of 74.40 euros per share, giving in to pressure from activist investor Elliott. Bain and Cinven last month won control of German generic drug maker Stada with a sweetened 5.3 billion-euro ($6.3 billion) bid, in the largest private-equity funded takeover of a German listed company, offering 66.25 euros per share. Elliott Management had said on Thursday, however, that it wanted at least 74.40 euros per share for its stake, which most recently stood at 13.3 percent, or 15.2 percent when taking stock options into account.